Found 28 matching trials
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas PHASE1 This is a pilot clinical trial investigating the addition of haploidentical...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma PHASE2 RATIONALE: Monoclonal antibodies can locate tumor cells and either kill the...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma PHASE2 The purpose of this study is to find out what effect an antibody called Hum...
Show More Status
Active Not Recruiting
Location
Children's Hospital of Los Angeles (Data Collection Only)
Learn More & Join Trial
Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma PHASE1 RATIONALE: Biological therapies such as beta-glucan use different ways to s...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Myeloablative Therapy and Autologous Stem-Cell Transplantation PHASE2 The purpose of this study is to see if high-dose 3F8 combined with GM-CSF i...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Humanized 3F8 Monoclonal Antibody (Hu3F8) When Combined With Interleukin-2 in Patients With High-Risk Neuroblastoma and GD2-positive Solid Tumors PHASE1 The purpose of this study is to find out if "humanized 3F8" (Hu3F8) when co...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma PHASE1 This is a safety / feasibility trial evaluating the combination of a humani...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
CH14.18 1021 Antibody and IL2 After Haplo SCT in Children With Relapsed Neuroblastoma PHASE2 A six courses regimen consisting of a 8 hour infusion (ch14.18/CHOmAb 20 mg...
Show More Location
University Hospital Graz
Learn More & Join Trial
Therapy for Children With Advanced Stage Neuroblastoma PHASE2 Neuroblastoma is the most common extracranial solid tumor in childhood, wit...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma PHASE2 RATIONALE: Monoclonal antibodies, such as monoclonal antibody 3F8, can loca...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial